Concepedia

Publication | Open Access

MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors

DOIFull Paper Access

39

Citations

26

References

2019

Year

Michaël H. Meel, Míriam Guillén Navarro, Mark C. de Gooijer, Dennis S. Metselaar, Piotr Waranecki, Marjolein Breur, Tonny Lagerweij, Laurine E. Wedekind, Jan Köster, Marianne D. van de Wetering,
Neuro-Oncology

Abstract

Altogether, we developed a combination treatment strategy for AT/RT based on MEK/MELK inhibition and identify therapeutically exploitable BBB deficiencies in these tumors.

References

YearCitations

Page 1